Shares of TransMedics Group ( TMDX 6.54%) recently bounded higher in response to a first-quarter earnings report that was a ...

The Organ Transport Devices Market is segmented by devices, disposables, perfusion solutions, and region from 2025 to 2035 Germany's organ transport devices market is poised to exhibit a CAGR of 5 ...

TransMedics posted strong Q1 results, easing fears of prior weakness and short pressure, while expanding logistics and ...

We discuss normothermic regional perfusion heart transplantation with ProCure On-Demand co-founder and CEO, Dr Zachary Kon.

TransMedics’ next-generation Organ Care System devices for heart and lung transplants ... The possibility of 24-hour organ perfusion, as indicated by early pre-clinical results, could ...

Germany’s organ transport devices market is poised to exhibit a CAGR of 5.5% between 2025 and 2035. Currently, it holds the highest share in the Western Europe market.” — Sabyasachi Ghosh, Principal ...

The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 ...

“It is technically challenging and complex to put [the organ] on these external perfusion devices,” said Correa. “It is also expensive.” There is currently a paucity of data comparing taNRP and DPP ...

Dr. Granger addressed organ transportation time at ... The inception of machine perfusion, in which a device pumps a blood-like solution through the donor heart during transport, has significantly ...

Dr. Granger addressed organ transportation time at today ... The inception of machine perfusion, in which a device pumps a blood-like solution through the donor heart during transport, has ...